Evidence map›Paper›PMID 26124772›Full record

ArticleFrontiers in genetics2015

Caenorhabditis elegans expressing the Saccharomyces cerevisiae NADH alternative dehydrogenase Ndi1p, as a tool to identify new genes involved in complex I related diseases.

Raynald Cossard, Michela Esposito, Carole H Sellem, Laras Pitayu, Christelle Vasnier, Agnès Delahodde, Emmanuel P Dassa

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Raynald CossardI2BC, Institute for Integrative Biology of the Cell, CEA, CNRS, Université Paris-Sud Orsay, France.
Michela EspositoI2BC, Institute for Integrative Biology of the Cell, CEA, CNRS, Université Paris-Sud Orsay, France.
Carole H SellemI2BC, Institute for Integrative Biology of the Cell, CEA, CNRS, Université Paris-Sud Orsay, France.
Laras PitayuI2BC, Institute for Integrative Biology of the Cell, CEA, CNRS, Université Paris-Sud Orsay, France.
Christelle VasnierI2BC, Institute for Integrative Biology of the Cell, CEA, CNRS, Université Paris-Sud Orsay, France.
Agnès DelahoddeI2BC, Institute for Integrative Biology of the Cell, CEA, CNRS, Université Paris-Sud Orsay, France.
Emmanuel P DassaI2BC, Institute for Integrative Biology of the Cell, CEA, CNRS, Université Paris-Sud Orsay, France.
Institut de Biologie Intégrative de la Cellule · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Isolated complex I deficiencies are one of the most commonly observed biochemical features in patients suffering from mitochondrial disorders. In the majority of these clinical cases the molecular bases of the diseases remain unknown suggesting the involvement of unidentified factors that are critical for complex I function. The Saccharomyces cerevisiae NDI1 gene, encoding the mitochondrial internal NADH dehydrogenase was previously shown to complement a complex I deficient strain in Caenorhabditis elegans with notable improvements in reproduction and whole organism respiration. These features indicate that Ndi1p can functionally integrate the respiratory chain, allowing complex I deficiency complementation. Taking into account the Ndi1p ability to bypass complex I, we evaluate the possibility to extend the range of defects/mutations causing complex I deficiencies that can be alleviated by NDI1 expression. We report here that NDI1 expressing animals unexpectedly exhibit a slightly shortened lifespan, a reduction in the progeny, and a depletion of the mitochondrial genome. However, Ndi1p is expressed and targeted to the mitochondria as a functional protein that confers rotenone resistance to those animals without affecting their respiration rate and ATP content. We show that the severe embryonic lethality level caused by the RNAi knockdowns of complex I structural subunit encoding genes (e.g., NDUFV1, NDUFS1, NDUFS6, NDUFS8, or GRIM-19 human orthologs) in wild type animals is significantly reduced in the Ndi1p expressing worm. All together these results open up the perspective to identify new genes involved in complex I function, assembly, or regulation by screening an RNAi library of genes leading to embryonic lethality that should be rescued by NDI1 expression.

Indexed as

Caenorhabditis eleganscomplex Iembryonic lethalityNdi1pRNAi screening

Identifiers

PMID26124772
PMCPMC4463008
OpenAlexW1524455332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.